Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04161248
Title Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications

B-cell lymphoma

primary mediastinal B-cell lymphoma

diffuse large B-cell lymphoma

Therapies

Cisplatin + Dexamethasone + Gemcitabine + Rituximab + Venetoclax

Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
BCCA - Vancouver Cancer Centre Recruiting Vancouver British Columbia V5Z 4E6 Canada Details
University Health Network Recruiting Toronto Ontario M5G 2M9 Canada Details
The Jewish General Hospital Recruiting Montreal Quebec H3T 1E2 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field